BHVN — Biohaven Ltd.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for BHVN in the TickerWise workspace.

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NYSE
• Employees: 256
• Website: https://www.biohaven.com

Latest SEC filings for BHVN

• 2026-10-158-K
• 2026-09-108-K
• 2026-08-268-K
• 2026-08-14SCHEDULE 13G
• 2026-08-108-K
• 2026-08-1010-Q
• 2026-08-078-K
• 2026-07-098-K
• 2026-07-08SCHEDULE 13G/A
• 2026-05-278-K

Latest BHVN news

• 2026-10-22Biohaven surges as FDA accepts resubmission for Vyglxia for spinocerebellar ataxia Read article
• 2026-10-08Biohaven licenses IgG degrader portfolio to Japan’s Ono Read article
• 2026-10-08Biohaven Expands Asian Licensing Footprint Through Strategic Ono Agreement Read article

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.